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Untargeted Metabolomics
Veronica Lelli, Antonio Belardo and Anna Maria Timperio
Abstract
Metabolomics is an emerging and rapidly evolving technology tool, which 
involves quantitative and qualitative metabolite assessments science. It offers 
tremendous promise for different applications in various fields such as medical, 
environmental, nutrition, and agricultural sciences. Metabolomic approach is based 
on global identification of a high number of metabolites present in a biological 
fluid. This allows to characterize the metabolic profile of a given condition and to 
identify which metabolites or metabolite patterns may be useful in the discrimina-
tion between different groups. The use of one mass spectrometry (MS) platform 
from targeted quantification to untargeted metabolomics will make more efficient 
workflows in many fields and should allow projects to be more easily undertaken 
and realized. Metabolomics can be divided into non-targeted and targeted. The first 
one can analyze metabolites derived from the organisms comprehensively and 
systematically, so it is an unbiased metabolomics analysis that can discover new 
biomarkers. Targeted metabolomics, on the other hand, is the study and analysis 
of specific metabolites. Both have their own advantages and disadvantages, and are 
often used in combination for discovery and accurate weight determination of dif-
ferential metabolites, and allow in-depth research and analysis of subsequent meta-
bolic molecular markers. Targeted and non-targeted metabolomics are involved in 
food identification, disease research, animal model verification, biomarker discov-
ery, disease diagnosis, drug development, drug screening, drug evaluation, clinical 
plant metabolism and microbial metabolism research. The aim of this chapter is to 
highlight the versatility of metabolomic analysis due to both the enormous variety 
of samples and the no strict barriers between quantitative and qualitative analysis. 
For this purpose, two examples from our group will be considered. Using non-
targeted metabolomics in opposite Antarctic cryptoendolytic communities exposed 
to the sun, we revealed specific adaptations. Instead, through the targeted metabo-
lomics applied to the urine during childbirth, we identified a different distribution 
of specific metabolites and the metabolic differences allowed us to discriminate 
between the two phases of labor, highlighting the metabolites most involved in the 
discrimination. The choice of these two approaches is to highlight that metabolomic 
analysis can be applied to any sample, even physiologically and metabolomically 
very distant, as can be microorganisms living on Antarctic rocks and biological 
fluids such as urine.
Keywords: urine, metabolite, HPLC–MS, fungus, biomarkers, system biology
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1. Metabolomics: the medicine of the third millennium
Metabolomics is a discipline thanks to whose analysis it is possible to ascertain 
the presence of biochemical imbalances caused by the lack of nutrients that are 
the basis of the functions of our body. With this research it is therefore possible to 
identify the true causes of any chronic disease and restore the biochemical balance 
of our body.
The use of “omics” sciences, especially metabolomics, has been having posi-
tive implications in recent years in the main actions of daily life, as monitoring the 
metabolism helps to keep energy levels, sleep and body weight under control. The 
operation is very simple: by measuring the metabolites present in the body, prob-
lems are identified and action is taken in a targeted and relevant way. An action of 
extraordinary effectiveness if you think about the current situation, for example in 
the food sector; nutrition today is very rich in calories but poor in nutrients, with 
the real risk of being overfed, but undernourished (Figure 1).
It is essential to remember that this is not an alternative medicine, but is comple-
mentary to other disciplines: in the face of even important pathologies, such as 
neoplasms, it will support the oncologist, improving the responses to cancer treat-
ment and helping to defeat the disease without interfering with the pathways of 
oncological treatment. A normal blood draw or a simple urine sample is sufficient 
to check the metabolites. An extraordinarily precise picture of the situation will 
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we can define as part of the so-called epigenetics, can directly influence the chemical 
aspect. The ultimate goal is to bring the body back to perfect efficiency, taking into 
account that the body tends by itself, by its nature, to the best possible state of health. 
However, when the body has difficulty repairing the damage or is facing a progressive 
problem, which does not have time to fix or lacks adequate resources, metabolomics 
comes to its rescue. Our body must be considered like a car: to function at its best, 
the best fuel is needed together with winning strategies of suitable equipment. This 
discipline, which is progressively affirming itself, has set itself the task of identifying 
the optimal conditions to support the architrave of human existence.
2. Targeted and untargeted metabolomics
The metabolome is the final downstream product of the genome and consists of all 
low molecular weight molecules (metabolites) in a cell, tissue or organism [1, 2]. The 
metabolic profile can provide a complete picture of that cell’s physiology. As emerg-
ing data suggest an important role for the microbiome and its metabolic products, 
the potential size of the metabolome is often highly controversial. Given the variety 
of chemical classes and physical properties that characterize metabolites and the 
dynamic range of metabolite concentrations over large orders of magnitude, a wide 
range of analytical techniques are required for metabolomics research. Metabolomics 
aims to identify and quantify multiple molecules in the context of physiological 
stimuli or in disease states. The “omics” revolution of the 1980s and 1990s provided 
new methodologies for the study of interactions on a global level and offered an 
alternative means of investigation to the more reductionist one in molecular biology. 
Omics is a field that aims to study the abundance and/or structural characterization of 
a wide range of molecules in organisms in distinct scenarios. In the clinical field, high-
throughput omics techniques are used for disease characterization to better predict 
the clinical course of organisms and to evaluate the efficacy of existing or developing 
therapies [3]. In food science, for example, omics plays a significant role in trying to 
improve human nutrition [4]. On the other hand, concerning the environment, omics 
studies aim to evaluate the alterations that organisms could undergo after exposure to 
environmental stressors [5, 6]. In recent years, a variety of omics subdisciplines have 
emerged (eg Fluxomics, lipidomics, glycomics, foodomics, interactomics and metal-
lomics), demonstrating that omics is a continuously evolving discipline and among all 
these platforms, metabolomics is becoming increasingly popular [7].
The first definition of metabolomics dates back to the 1990s, describing tech-
niques aimed at identifying existing metabolites within a cell, tissue or organism 
during a genetic alteration or physiological stimulus [8, 9]. Metabolomics has been 
shown to be complementary to other omics techniques, thus identifying - called 
silent phenotypes - genes that when perturbed have no apparent influence on physi-
cal characteristics or behavior [10]. The metabolomic approach can be conducted in 
two distinct ways; non-targeted approach and targeted approach [11].
The reason for this differentiation is due to the different types of data generated 
in these two approaches, which must be handled accordingly (Figure 2). Targeted 
studies focus research on a number of known metabolites, while non-targeted studies 
allow for a more comprehensive evaluation of metabolomic profiles. Most of the 
methodologies used in the first targeted studies only allowed for the identification 
of a limited number of metabolites. However, recent targeted methodologies allow 
for the creation of large-scale metabolic profiles, including hundreds of compounds. 
However, the number of compounds analyzed in non-targeted studies is even greater. 
This is because entire datasets, including thousands of metabolic signals, need to be 




Untargeted approaches provide the most correct path to detect unexpected 
changes in metabolite concentrations. The goal is to maximize the number of 
metabolites detected and thus provide the opportunity to observe unexpected 
changes. However, a single analytical method cannot detect all metabolites in a bio-
logical system. It is therefore necessary to combine multiple analytical approaches 
(such as complementary HPLC methods) to maximize the number of metabolites 
detected and improve metabolome coverage.
Sample preparation in non-targeted studies consists of extracting the metabo-
lites from the biological sample in a suitable solvent for analytical analysis. The 
extracted sample is analyzed with an appropriate analytical method (for example, 
LC–MS). The result of the mass spectrometry analysis is a chromatogram and the 
peak area of  each metabolite is used as a parameter in the statistical analysis to 
define the concentration differences between the different biological samples mea-
sured. This is called relative quantification as there is no comparison with calibra-
tion curves constructed from chemical standards. The use of calibration curves is 
indispensable for full quantification. The biological significance of each metabolite 
is determined during data analysis and metabolite identification, and biological 
interpretation is performed at the end of the experimental pipeline. Currently, one 
of the main limitations in non-targeted approaches is the identification of metabo-
lites. It may not be possible to identify the metabolites highlighted in the statistical 
analysis as significant changes between biological classes in the study. The identifi-
cation of metabolites is currently one of the hot topics of metabolomics.
4. Targeted approaches
Targeted studies investigate a relatively limited and specific number of metabo-
lites. At the start of the study, before data acquisition is performed, the metabolites 
are chemically characterized and biochemically annotated. Targeted methods have 
greater selectivity and sensitivity than non-targeted methods. A targeted study 
Figure 2. 
Targeted and untargeted approach.
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can only be performed if a genuine chemical standard of the metabolite is avail-
able. The quantification of metabolites is performed using internal and chemical 
standards to construct calibration curves for each of the metabolites under study. 
Sample preparation in targeted studies applies methods that can be optimized to 
retain metabolites of interest and to remove other biological species and analytical 
artifacts that are not performed via downstream analysis.
Therefore, data analysis strategies for non-targeted studies require very exten-
sive chromatogram processing. A large number of data analysis strategies are found 
in the literature, but none of them can be considered the optimal choice in all cases, 
which makes data analysis an open task in bioinformatics research. In fact, the field 
of MS-based metabolomics is quite young and new methods, software and plat-
forms are regularly published or updated.
The data are produced by chemical–physical investigation techniques such as 
magnetic resonance spectroscopy, chromatography and mass spectrometry applied 
to biofluid samples or suitably selected solid tissues. These methodologies find 
today numerous possibilities of use in the field of medical sciences where there are 
numerous variables detectable on human and animal subjects that present a specific 
pathology. This approach is valid both for the description of existing pathologies 
and for the identification of pre-pathological stages. The use of metabolomic meth-
ods can help provide an overall - holistic - view of the problem, highlighting the 
relationships between variables and their relative importance, and can also high-
light differences and similarities between samples. Considering individual biologi-
cal processes as isolated processes expresses a reductionist view of vital functions, 
an abstraction that at times makes it possible to considerably simplify the problem 
under consideration but which inevitably leads to models of limited value.
5. Metabolomics techniques
There is a range of analytical chemistry tools applied in metabolomics research.
Each instrument has advantages and limitations, and no single instrument or 
instrumental method can detect all of the metabolites present in a metabolome, but 
multiple instrumental methods or multiple different instruments are required to 
provide the largest number of metabolites detected.
Several analytical techniques have been developed for each of the omics plat-
forms, including techniques based on DNA microarray and RNA sequencing [12], 
nuclear magnetic resonance (NMR) spectroscopy [13, 14] and mass spectrometry 
(MS) [15, 16]. NMR and MS are the most used in the field of metabolomics. High 
resolution proton NMR spectroscopy (1H-NMR) has proven to be one of the best 
technologies for examining biofluids and studying intact tissues, as the result is a 
complete signal profile of metabolites without separation, derivatization and pre-
selected measurement parameters [17, 18]. On the other hand, MS methods, both by 
direct injection [19] and coupled with chromatographic techniques [20], have also 
evolved into an excellent technology for metabolomics due to their ability to analyze 
low molecular weight compounds in biological systems. These two approaches 
(NMR and MS) are complementary and the integration of both technologies can 
provide more comprehensive information in the field of metabolomics.
Applications of metabolomics have expanded in line with genomics, proteomics 
and transcriptomics with the aim of determining gene function in microbes [21], 
plants [22] and animals [23]. Many different applications are also used today, 
such as the determination of metabolic biomarkers that change as an indicator of 
the presence of a disease or in response to a pharmacological intervention or the 
determination of the effect of biochemical or environmental stress on plants or 
Metabolomics
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microbes, genetically modified plants [24], bacterial characterization [25], health 
status assessments [26] and metabolic engineering [27].
5.1 Gas chromatography–mass spectrometry (GC–MS)
GC–MS is a combined system in which volatile and thermally stable compounds 
are first separated from the GC and then the eluted compounds are detected 
by electron impact mass spectrometers. During the run, aliquots of derivatized 
samples (injection volumes of 1 μl or less) are analyzed using split and splitless 
techniques on different polarity GC columns (DB-5 or DB-50 or similar capillary 
columns in stationary phase are most commonly used). These provide both high 
chromatographic resolution of compounds and high sensitivity (typical limits of 
detection are concentrations of pmol or nmol). Quantification is provided by exter-
nal calibration or response ratio (metabolite peak area/internal standard peak area). 
The coverage of the metabolome is largely characterized by the volatility of the 
non-derivatized or derivatized sample components. The identification of metabo-
lites is provided by matching the retention time and mass spectrum of the sample 
peak with those of a pure compound previously tested on the same or a different 
instrument under identical instrumental conditions [28]. Since the electron impact 
mass spectrometer provides the standard fragmentation of molecular ions during 
ionization, structural identification can be performed through the interpretation of 
fragment ions and fragmentation patterns.
5.2 Liquid chromatography-mass spectrometry (LC–MS)
LC–MS provides separation of metabolites by liquid chromatography followed 
by electrospray ionization (ESI) or, less typically, atmospheric pressure chemical 
ionization (APCI) [29]. This technique differs from GC–MS for several reasons 
(lower assay temperatures and unsolicited sample volatility) and this simpli-
fies sample preparation. In most non-pharmaceutical applications, samples are 
prepared after intracellular extraction and/or protein precipitation by dilution 
in an appropriate solvent. The chemistry and HPLC column size used will affect 
chromatographic resolution and sensitivity. Analytical columns do not provide the 
chromatographic resolving power to separate these complex samples and run times 
of 10 minutes followed by chemometric instruments are used to extract the chro-
matographically unsolved data and classify the differences between the samples 
[30]. The application of very high-pressure chromatography systems can improve 
the chromatographic resolution. The most common column chemicals used today 
are reverse phase C 18 or C 8 columns. However, for polar metabolites injected on 
these columns, the retention of these metabolites is minimal, thus reducing the 
volume of interpretive data. To overcome this problem, other chemical columns are 
needed, such as HILIC [31] and other weak ion exchange chemicals. The sample 
then, once the chromatographic separation has been carried out, reaches the source 
of the mass spectrometer. Electrospray instrumentation operates in positive and 
negative ion modes (as separate experiments or by polarity switching during analy-
ses) and detects only those metabolites that can be ionized by adding or removing 
a proton or adding another species of ions. Metabolites are generally detected in 
one but not both ion modalities, so broader metabolic coverage can be achieved by 
analysis in both modalities. Quantification is performed by external calibration. ESI 
does not cause molecular ion fragmentation as observed in electron impact mass 
spectrometers, thus it does not allow direct identification of metabolites by com-
paring ESI mass spectra, as ESI mass spectral libraries are not commonly available 
(as in the case by GC–MS). However, with the use of accurate mass measurements 
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and/or tandem MS (MS/MS) to provide collision induced dissociation (CID) and 
correlated mass spectra (MS/MS), correct identification of metabolites can be 
achieved [30].
5.3 Direct injection mass spectrometry (DIMS)
DIMS is shown as a high-throughput screening tool (hundreds of samples per day 
with a run time generally of 1 minute). The extracts of the crude sample are injected 
or infused into an electrospray mass spectrometer and results in a mass spectrum 
per sample, which is representative of the composition of the sample. The ioniza-
tion capacity of the metabolite determines metabolic coverage, as for LC–MS. The 
applications of DIMS are mainly concentrated in the microbial [32] and plant areas.
5.4 Fourier transform infrared spectroscopy (FT-IR)
Vibrational spectroscopy techniques such as Fourier transform infrared spec-
troscopy (FT-IR) and Raman spectroscopy have been used to analyze metabolic 
changes in biological samples. The methodologies consist of passing ultraviolet or 
infrared light through a sample before it is detected. The vibrations and rotations of 
the bonds relating to different chemical groups resulting from the interaction of the 
sample with ultraviolet or infrared light are mainly measured.
The problem with these techniques is the inability to detect each metabolite sep-
arately; instead, it is a specific technique for single molecules that will absorb ultra-
violet or infrared light at specific wavelengths. In FT-IR, a metabolic fingerprint is 
taken with a single absorption spectrum collected for each sample and consisting of 
information for many metabolites. The result is similar to data produced by direct 
infusion mass spectrometry where a single mass spectrum is collected rather than 
an absorption spectrum for each sample. The metabolic fingerprints produced in 
these approaches lack the sensitivity of mass spectrometry but are a useful tool for 
high throughput screening since the FT-IR analysis time is approximately one min-
ute per sample. To date, the vast majority of metabolomic studies undertaken using 
vibrational spectroscopy have been performed with FT-IR spectroscopy. However, 
the work was done using Raman and, in terms of metabolomics, this is an emerging 
technology with significant potential for metabolite monitoring [33].
5.5 Nuclear magnetic resonance (NMR)
Nuclear magnetic resonance (NMR) spectroscopy applies the magnetic proper-
ties of atomic nuclei in a metabolite. Only some atoms are active NMRs and include 
1H, 13C and 31P. Proton (1H) NMR spectroscopy is the most frequently applied 
in metabolomics. The technique works by inserting a liquid sample into a small 
internal diameter tube (about 5 mm), where it is pulsed with a range of radio 
frequencies that cover all possible energies required to excite the selected type of 
nuclei. Nuclei absorb energy at different radio frequencies depending on their 
chemical environment and then the release of this energy is measured, forming 
what is called a free induction decay (FID). This FID is converted from a time 
domain data set to a frequency domain - using a Fourier transformation - and an 
NMR spectrum is constructed as the absorption energy plotted against the peak 
intensity. The NMR spectrum (in particular the chemical shift) depends on the 
effect of the shielding by the electrons orbiting the nucleus. The chemical shift for 1 
H NMR is determined as the difference (in ppm) between the resonance frequency 
of the observed proton and that of a reference proton present in a reference com-
pound (for 1 H NMR experiments, tetramethyl-silane in solution, fixed at 0 ppm). 
Metabolomics
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The intensity of the signal depends on the number of identical nuclei and the 
presence of complex samples does not interfere with the measured intensity, as does 
the suppression of ionization with electrospray ionization. NMR spectroscopy is a 
high-speed fingerprinting technique. Raw samples are mixed with a solution of the 
reference compound added to an NMR probe (usually less than 2 mL), inserted into 
the instrument and analyzed. NMR probes are generally based on a large volume of 
μl and this adds constraints to the required sample volume. However, the introduc-
tion of 1 mm μl probes allowed to analyze volumes of 2 μl, thus enabling invasive 
sampling of smaller volumes of study subjects, which is important for small animal 
studies [10]. Spectra are complex and contain thousands of metabolic signals. For 
data processing, the spectrum is generally divided into chemical shift ranges with 
widths of 0.02–0.04 ppm. All signals in this bucket are added together. Chemical 
changes can be assigned to specific metabolites and the pure metabolite can be 
added for further clarification. However, the spectrum model is generally used in 
sample classification, similar to that used for FT-IR and DIMS.
6. Examples of metabolomics studies
6.1 Urine metabolomics
The metabolic profile of biofluids has emerged as an important tool in the 
diagnosis of numerous diseases that remain silent until late progression of the 
disease [34]. Because urine is such a rich source of biomarkers, the metabolic 
profile is a promising tool for assessing therapeutic efficacy. Urine collection is 
also non-invasive, does not require patient preparation and substantially improves 
compliance. Recent results clearly demonstrate the potential of urine metabolomics 
in diagnosis by providing new insights into the biochemistry of its pathophysiology 
[35]. The qualitative/quantitative analysis on the urine of pregnant women between 
two different stages of labor called OL (out of labor) and IL-DP (in labor in the 
dilation phase), using as a technique the ultra-performance liquid chromatography 
of hydrophilic interaction coupled with mass spectrometry (HILIC-UPLC–MS), 
a highly sensitive, accurate and unbiased approach, are an example [36]. The list 
of metabolites is shown in Table 1. The urinary metabolites showing the great-
est differences belong to the steroid hormone, in particular conjugated estrogens 
and amino acids, much of this difference being determined by fetal contribution. 
The increased excretion of conjugated estrogens in the DP stage may confirm the 
coordinated role played between fetus, mother and placenta during labor. It is 
reasonable to consider this terminal phase of pregnancy not only as a mechanical 
event linked to the increase in uterine contractions, but as a more complex process. 
Figure 3 shows the major compounds excreted in the urine (such as Estradiol 
Glucoronide, Estrone 3-Sulphate and Estriol Glucuronate) which are downstream 
of a more intricate process. These compounds originate from an interconnected 
metabolism between mother-fetus and placenta involving steroid hormones. As 
seen in Figure 3, the metabolites excreted can come directly from the mother, 
or with the contribution of both the placenta and the fetus. In the latter case, 
the excretion of metabolites occurs through the degradation of intermediates, in 
particular the hormone pregnenolone.
6.2 Antarctic cryptoendolithic communities
Antarctic cryptoendolite communities are microbial ecosystems that dominate 
the biology of most ice-free areas in mainland Antarctica. These are complex and 
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self-supporting assemblies formed by the association of autotrophic and hetero-
trophic microorganisms such as Bacteria Chlorophyta and Fungi, which live at the 
limit of their physiological adaptability and this represent the only possibility of 
survival before extinction. They live inside the pores of the rocks creating an envi-
ronment that protects them from environmental stress, they are extremely tolerant 
and remarkably resistant to stress and finally they adapt perfectly to the lithic life 
(Figure 4A).
The study was conducted on the basis of the different solar exposure, verifying 
how this factor influences the production of key metabolites and therefore on the 
adaptation strategies implemented by these microorganisms to survive in extreme 
conditions (Figure 4B). The result is the presence of 331 altered and differentially 
expressed metabolites [37]. All intermediates of melanogenesis are found in the 
highest concentration in south facing rocks (Table 2). Organisms have developed 
Compounds Molecular weight Percentage
3 hydroxy2-methyl-1H-quinolin-one 175.05 3% - up
19 chloro19-Chloro-3beta-hydroxyandrost-5-en-17-
one = dehydroepiandrosterone
365.1695 95% - up
Androst-5-ene-3beta,17beta-diol = androsterone 290.1736 21% - down
Androsterone 290.1736 21% - down
Dehydroepiandrosterone Sulfate 369.0992 92% - down
Dehydroepiandrosterone 288.1873 3% - down
Pregnanediol 321.2145 25% - down
3-Hydroxy-1-methylestra-1,3,5(10),6-tetraen-17-one 283.1551 63% - up
Tetrahydrocortisone 365.1592 88% - down
Estrone 3 sulfate 351.1085 >100% - up
Estrone gluconoride 447.1790 87% - down
Estradiol 17 beta 3 gluconoride 449.1945 42% - up
Ser 105.09 59% - down
Val 117.15 35% - up
His 155.15 23% - up
Arg 174.20 11% - up
Cys 121.16 47% - up
Ala 89.09 47% - down
Glu 147.13 85% - up
Gln 146.14 25% - up
Leu 131.17 38% - up
Lys 146.19 60% - up
Ile 131.17 38% - up
Thr 119.12 18% - up
Phe 165.19 11% - down
Tyr 181.19 12% - down
Table 1. 
Estrogen and amino acid amount extracted from the urine in the two stages of pregnancy (OL and IL-DP). The 
table refers to the relative concentration of the metabolites calculating as a percentage of the total compounds by 




A coordinated cycle between mother fetus and placenta through the biosynthesis of steroid hormones.
Figure 4. 
A - Communities stratified on rocks. B - Antarctic cryptoendolite communities. The yellow arrow indicates the 
north-facing surface, while the white arrow indicates the south-facing surface. (Figure 4B comes from Coleine 
et al. [37].
Compound Molecular weight Regulation
Gentisyl alcohol 140.14 Down
Hypoxanthine 136.11 Down
6- Methoxymellein 208.21 Down
Allantoin 158.12 Down
DOPA 197.18 Up
5,6-Hydroxy indole 133.15 Up
Anthocyanin 3-O-β-D glucoside 449.38 Up
Plastoquinone 749.2 Up
Xanthine 152.11 Down
Uric acid 168.11 Down
Tyrosine 181.19 Up
11
From Targeted Quantification to Untargeted Metabolomics
DOI: http://dx.doi.org/10.5772/intechopen.96852
metabolic profiles responding to the condition of deprivation of sunlight, in fact 
in fungi, melanin performs functions such as photoprotection, energy conver-
sion, protection from thermal stress, metal chelation, resistance to drying and cell 
strengthening. Therefore, every organism that lives in non-optimal conditions has 
the ability to modify its biological functions and its structures according to external 
dynamics. The adaptation analysis allowed to demonstrate how the environment, 
and in particular the solar exposure, can strongly influence the olic phenotype of 
these microbial communities, demonstrating how the direct incidence of sunlight in 
one case, or their absence in the other, it has determined the acquisition of various 
adaptations by the colonizing species aimed at favoring their growth and guaran-
teeing their survival in such a hostile environment.
7. Conclusion
Starting from a holistic approach, with a high-throughput non-targeted 
metabolomics without prior knowledge of the metabolome, it is possible to find 
biologically relevant metabolites (potential biomarkers), characteristic of targeted 
metabolomics as shown by the two examples described in this chapter. In the case 
of urinary metabolites hundreds of metabolites are represented but the major 
differences between OL and IL-DP belong to the steroid hormone, in particular to 
conjugated estrogens and amino acids. These compounds could predict the time to 
delivery in pregnant women.
As for the Antarctic cryptoendolytic communities, among the candidates to be 
considered biomarkers, the precursor metabolites of the melanin and allantoin 
pathways emerged as these were the most affected by exposure to the sun. These 
paths can be considered directly involved in the response to environmental 
pressure. In conclusion, both targeted and non-targeted metabolomics are then 
used in combination for the detection and accurate weighting of differential 
metabolites. Furthermore, the types of metabolites that are recovered are 
influenced by the extraction and the analytical method chosen. In this chapter 
the main devices used have been summarized, subsequently the results will 
require computational tools to identify and correlate the metabolites among the 
samples to examine their connection in the metabolic pathways in relation to the 
phenotype.
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Indole 5,6- quinone 147.13 Up
Table 2. 
Regulation of metabolites in Antarctic cryptoendolithic communities exposed to the south in the absence of sun 
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Abbreviations
CID Collision induced dissociation
DIMS Direct Injection Mass Spectrometry
FID Free induction decay
FT-IR Fourier Transform Infrared Spectroscopy
GC–MS Gas Chromatography–Mass Spectrometry
HILIC Hydrophilic interaction chromatography
HPLC High performance liquid chromatography
IL-DP In labor in the dilation phase
LC–MS Liquid Chromatography-Mass Spectrometry
MS Mass spectrometry
NMR Nuclear magnetic resonance
OL Out of labor
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